InsidersTradesSigma
Explore the complete record of transactions filed by GLENN JOHN, Chief Financial Officer. Officer active across 1 companies, notably Ekso Bionics Holdings, INC.. Aggregated, 2 reports have been recorded. Total volume traded: €9k. The latest transaction was disclosed on 22 March 2022 — Cession. Regulator: SEC (Form 4). The full history is free.
2 of 2 declarations
John Glenn is the Chief Financial Officer at Ekso Bionics Holdings, Inc. He is responsible for the company's financial management, overseeing accounting and financial operations. His role is essential in ensuring financial transparency and compliance with regulations.